Burkholderia cepaciaLower Respiratory Tract Infection Associated With Exposure to a Respiratory Therapist
- 1 July 2001
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 22 (7) , 423-426
- https://doi.org/10.1086/501928
Abstract
Objective: : To investigate and control a nosocomial outbreak ofBurkholderia cepacialower respiratory tract infection.Design: : Outbreak investigation and case-control study.Setting: : A 260-bed community hospital.Patients: : Participants were mechanically ventilated intensive care patients without cystic fibrosis. A case was defined as a hospitalized patient with a sputum culture positive forB cepaciabetween January 1 and November 6, 1998.Methods: : Respiratory therapy infection control policies and practices were reviewed; laboratory and environmental studies and a retrospective case-control study were conducted. Case-patients were matched with control-patients on age, gender, diagnosis, and type of intensive care unit.Results: : Nine case-patients were identified;B cepacialikely caused pneumonia in seven and colonization in two. Two respiratory therapy practices probably contributed to the transmission ofB cepacia:multidose albuterol vials were used among several patients, and nebulizer assemblies often were not dried between uses.B cepaciawas grown from cultures of three previously opened multidose vials; pulsed-field gel electrophoresis patterns ofB cepaciafrom seven case-patients and two multidose vials were indistinguishable. Case-patients had longer durations of heated humidified mechanical ventilation (mean, 9.8 days vs 4.4 days;P=.03) and were more likely to have exposure to one particular respiratory therapist than controls (odds ratio, undefined; 95% confidence interval, 4.7-∞P=.001). The association with the respiratory therapist, a temporary employee, persisted after controlling for duration of heated humidified ventilation. No newB cepaciainfections were identified after control measures were implemented.Conclusions: : B cepaciaprobably was transmitted among patients through use of extrinsically contaminated multidose albuterol vials. Respiratory therapy departments must pay close attention to infection control practices, particularly among new or temporary staff.Keywords
This publication has 13 references indexed in Scilit:
- Commercial Use of Burkholderia cepaciaEmerging Infectious Diseases, 1999
- Burkholderia cepacia: medical, taxonomic and ecological issuesJournal of Medical Microbiology, 1996
- Nosocomial Burkholderia cepacia Outbreaks and Pseudo-OutbreaksInfection Control & Hospital Epidemiology, 1996
- Survival of Burkholderia cepacia on environmental surfacesJournal of Hospital Infection, 1996
- Burkholderia cepacia and Nebulized AlbuterolAnnals of Internal Medicine, 1996
- Nosocomial Outbreak of Pseudomonas cepacia Associated with Contamination of Reusable Electronic Ventilator Temperature ProbesInfection Control & Hospital Epidemiology, 1993
- Ventilator temperature sensors: an unusual source of Pseudomonas cepacia in nosocomial infectionJournal of Hospital Infection, 1993
- Nosocomial Outbreak of Pseudomonas cepacia Respiratory Infection in Immunocompromised Patients Associated with Contaminated Nebulizer DevicesKansenshogaku Zasshi, 1993
- Pseudomonas cepacia: Biology, mechanisms of virulence, epidemiologyThe Journal of Pediatrics, 1986
- Pseudomonas cepacia infection in cystic fibrosis: An emerging problemThe Journal of Pediatrics, 1984